.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Novartis
Argus Health
QuintilesIMS
Dow
Teva
US Army
Julphar
Harvard Business School
McKesson

Generated: September 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Use of pramipexole in the treatment of restless legs syndrome
Abstract:The present invention provides the use of pramipexole in the treatment of restless legs syndrome.
Inventor(s): Oertel; Wolfgang H. (Ranschenberg, DE), Meier; Dieter (Weisbaden, DE), Gomez-Mancilla; Baltazar (Portage, MI), Montplaisir; Jacques (Montreal, CA)
Assignee: Pharmacia & Upjohn Company (Kalamzoo, MI)
Application Number:09/008,212
Patent Claims: 1. A method for treating restless legs syndrome in a patient suffering from or susceptible to such condition comprising the administration of an effective amount of the compound 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole, its (-)-enantiomer thereof, and pharmacologically acceptable salts thereof.

2. A method for treating restless legs syndrome in a patient suffering from or susceptible to such condition comprising the administration of an effective amount of Pramipexole, its dihydrochoride, or its dihydrochloride-(H.sub.2 O) thereof.

3. The method of claim 2, wherein the dose of Pramipexole is about 0.01-10.0 mg/day.

4. The method of claim 2, wherein the dose of Pramipexole is between about 0.75-4.5 mg/day.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Cantor Fitzgerald
Baxter
US Army
Healthtrust
UBS
Novartis
Farmers Insurance
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot